On November 26, 2024, Christian Voigtlander, Chief Operating Officer of ICU Medical Inc's subsidiary, sold 9,681 shares of ICU Medical Inc (ICUI, Financial). Following this transaction, the insider now owns 0 shares of the company. This sale is part of a broader trend, as over the past year, Christian Voigtlander has sold a total of 35,823 shares and purchased none.
ICU Medical Inc is a company that develops, manufactures, and sells medical devices used in infusion therapy and critical care applications. The company's product portfolio includes IV solutions, IV smart pumps, and other related products.
The insider transaction history for ICU Medical Inc indicates that there have been 0 insider buys and 20 insider sells over the past year. This trend suggests a pattern of selling among insiders.
On the day of the recent sale, shares of ICU Medical Inc were trading at $161.13, giving the stock a market cap of $3.860 billion. The GF Value of the stock is estimated at $174.88, resulting in a price-to-GF-Value ratio of 0.92. This indicates that the stock is modestly undervalued according to its GF Value.
The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow. It also considers a GuruFocus adjustment factor based on the company’s past returns and growth, as well as future estimates of business performance from Morningstar analysts.
For more details on this transaction, refer to the SEC Filing.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
